The market performance of Ultragenyx Pharmaceutical Inc. has been somewhat stable. Over the past year, the company’s stock achieved a high of $54.98 on 06/06/23, with the lowest value for the same timeframe being $31.52, recorded on 10/24/23.
52-week price history of RARE Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Ultragenyx Pharmaceutical Inc.’s current trading price is -8.62% away from its 52-week high, while its distance from the 52-week low is 59.39%. The stock’s price range during this period has fluctuated between $31.52 and $54.98. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.98 million for the day, which was evidently higher than the average daily volume of 0.74 million over the last three months.
Financial Performance and Market Capitalization
Ultragenyx Pharmaceutical Inc. (RARE) has experienced a quarterly rise of 6.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.14B and boasts a workforce of 1276 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 45.45, with a change in price of +15.29. Similarly, Ultragenyx Pharmaceutical Inc. recorded 754,804 in trading volume during the last 100 days, posting a change of +43.75%.
RARE Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RARE stands at 3.39. Similarly, the long-term debt-to-equity ratio is also 3.24.
RARE Stock Stochastic Average
Ultragenyx Pharmaceutical Inc.’s raw stochastic average for the past 50 days is currently at 64.94%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 77.71%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 45.40% and 31.62%, respectively.
RARE Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 5.06%.However, over the last six months, we can see a weaker performance of 46.73%. Over the last 30 days, the price of RARE has leaped by -1.99%. And in the last five days, it has surged by 7.60%.
